Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition

Twist1 is highly expressed in primary and metastatic non-small cell lung cancer (NSCLC), and thus acts as a critical target for lung cancer chemotherapy. In the current study, we investigated the underlying mechanism initiated by silencing of Twist1 that sensitizes NSCLC cells to cisplatin. Silencin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, H-O, Hong, S-E, Woo, S-H, Lee, J-H, Choe, T-B, Kim, E-K, Noh, W-C, Lee, J-K, Hong, S-I, Kim, J-I, Park, I-C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388235/
https://www.ncbi.nlm.nih.gov/pubmed/22673193
http://dx.doi.org/10.1038/cddis.2012.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388235/
https://www.ncbi.nlm.nih.gov/pubmed/22673193
http://dx.doi.org/10.1038/cddis.2012.63

Ejemplares similares